Krsnaa Diagnostics Limited (NSEI: KRSNAA)
Health Care · Health Care Providers & Services · IN
Rs561.65
-2.37% today · -29.8% 1Y
Krsnaa Diagnostics Limited (NSEI: KRSNAA) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $190.42M and employs 3,700 people.
Over the last twelve months the share price has lost 29.8%, trading between 515.00 and 894.40.
Tweenvest scores Krsnaa Diagnostics Limited across four factors: quality 66/100, value 76/100, growth 58/100, dividend 41/100. Its strongest factor is value.
KRSNAA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $190.42M
- Revenue (TTM)
- $88.98M
- P/E
- 18.93
- EPS
- 29.67
- Dividend yield
- 0.36%
- Beta (5Y)
- 0.06
- 52-week high
- Rs894.40
- 52-week low
- Rs515.00
- Avg volume (3M)
- —
- Shares outstanding
- 32.44M
- Employees
- 3,700
- Next earnings
- —
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited specializes in delivering a comprehensive range of diagnostic solutions. The company utilizes technology to provide services such as radiology, clinical pathology, and tele-radiology to diverse clients, including public and private healthcare facilities, medical colleges, and local community health centers. By December 31, 2020, its extensive network featured 1,801 diagnostic centers distributed across 13 Indian states. Established in 2010, the company maintains its headquarters in Pune, India.
- Founded
- 2010
- Listed since
- Aug 16, 2021
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.